<p>Nonoperative Management of Rectal Cancer The Watch and Wait Strategy</p>
Carregando...
Citações na Scopus
8
Tipo de produção
article
Data de publicação
2022
Título da Revista
ISSN da Revista
Título do Volume
Editora
W B SAUNDERS CO-ELSEVIER INC
Autores
Citação
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, v.31, n.2, Special Issue, p.171-182, 2022
Resumo
Over the past few decades, rectal cancer management has become increasingly challenging for multiple reasons. Proper imaging using dedicated magnetic resonance (MR), standardization of total mesorectal excision (TME), and incorporation of neoadjuvant treatment regimens have contributed to a significant decrease in local recurrence rates while minimizing the need for definitive stomas (therefore allowing for sphincter-preservation alternatives).1 & ndash;3 However, the observation of complete tumor response to radiation (RT) or chemoradiation (CRT) led to the proposal of organpreservation strategies with avoidance of immediate surgery and close surveillance (Watch and Wait strategy) in selected patients.4 Initially considered for a very restricted subgroup of patients, the use of more contemporary neoadjuvant treatment regimens has resulted in a higher proportion of patients achieving complete tumor regression.5 The purpose of the present article is to review the current evidence related to the selection criteria and outcomes in patients enrolled in this Watch and Wait strategy. <comment>Superscript/Subscript Available</comment
Palavras-chave
Watch & wait, Organ preservation, Rectal cancer, Neoadjuvant therapy, Clinical complete response
Referências
- Bettoni F, 2017, ANN SURG, V265, pE4, DOI 10.1097/SLA.0000000000001937
- Burton S, 2006, BRIT J CANCER, V94, P351, DOI 10.1038/sj.bjc.6602947
- Carpinetti P, 2015, ONCOTARGET, V6, P38360, DOI 10.18632/oncotarget.5256
- Cercek A, 2018, JAMA ONCOL, V4, DOI 10.1001/jamaoncol.2018.0071
- Chadi SA, 2018, LANCET GASTROENTEROL, V3, P825, DOI 10.1016/S2468-1253(18)30301-7
- Chow OS, 2016, ANN SURG ONCOL, V23, P2548, DOI 10.1245/s10434-016-5205-4
- Dattani M, 2018, ANN SURG, V268, P955, DOI 10.1097/SLA.0000000000002761
- dos Anjos DA, 2016, DIS COLON RECTUM, V59, P805, DOI 10.1097/DCR.0000000000000655
- El Sissy C, 2020, CLIN CANCER RES, V26, P5198, DOI 10.1158/1078-0432.CCR-20-0337
- Fernandez LM, 2021, LANCET ONCOL, V22, P43, DOI 10.1016/S1470-2045(20)30557-X
- Fernandez LM, 2020, DIS COLON RECTUM, V63, P1053, DOI 10.1097/DCR.0000000000001707
- Ganesh K, 2019, NAT MED, V25, P1607, DOI 10.1038/s41591-019-0584-2
- Habr-Gama A, 1998, DIS COLON RECTUM, V41, P1087, DOI 10.1007/BF02239429
- Habr-Gama A, 2004, ANN SURG, V240, P711, DOI 10.1097/01.sla.0000141194.27992.32
- Habr-Gama A, 2019, DIS COLON RECTUM, V62, P675, DOI 10.1097/DCR.0000000000001337
- Habr-Gama A, 2019, DIS COLON RECTUM, V62, P802, DOI 10.1097/DCR.0000000000001338
- Habr-Gama A, 2016, DIS COLON RECTUM, V59, P264, DOI 10.1097/DCR.0000000000000543
- Habr-Gama A, 2014, MINIM INVASIV THER, V23, P63, DOI 10.3109/13645706.2014.893891
- Habr-Gama A, 2014, INT J RADIAT ONCOL, V88, P822, DOI 10.1016/j.ijrobp.2013.12.012
- Habr-Gama A, 2013, DIS COLON RECTUM, V56, P1109, DOI 10.1097/DCR.0b013e3182a25c4e
- Habr-Gama A, 2010, DIS COLON RECTUM, V53, P1692, DOI 10.1007/DCR.0b013e3181f42b89
- Hasan S, 2020, ANN SURG, V271, P716, DOI 10.1097/SLA.0000000000003051
- Heald RJ, 2014, COLORECTAL DIS, V16, P334, DOI 10.1111/codi.12627
- HEALD RJ, 1986, LANCET, V1, P1479
- HEALD RJ, 1982, BRIT J SURG, V69, P613, DOI 10.1002/bjs.1800691019
- Hompes R, 2013, COLORECTAL DIS, V15, pe576, DOI 10.1111/codi.12381
- Hupkens BJP, 2017, DIS COLON RECTUM, V60, P1032, DOI 10.1097/DCR.0000000000000862
- Kalady MF, 2009, ANN SURG, V250, P582, DOI 10.1097/SLA.0b013e3181b91e63
- Kong JC, 2017, DIS COLON RECTUM, V60, P335, DOI 10.1097/DCR.0000000000000754
- Lambregts DMJ, 2017, EUR RADIOL, V27, P4445, DOI 10.1007/s00330-017-4830-z
- Lambregts DMJ, 2016, EUR RADIOL, V26, P2118, DOI 10.1007/s00330-015-4062-z
- Lambregts DMJ, 2015, ANN SURG, V262, P1034, DOI 10.1097/SLA.0000000000000909
- Lambregts DMJ, 2011, DIS COLON RECTUM, V54, P1521, DOI 10.1097/DCR.0b013e318232da89
- Lefevre JH, 2016, J CLIN ONCOL, V34, P3773, DOI 10.1200/JCO.2016.67.6049
- Lopes-Ramos C, 2015, CANCER GENET-NY, V208, P319, DOI 10.1016/j.cancergen.2015.03.010
- Maas M, 2015, ANN SURG ONCOL, V22, P3873, DOI 10.1245/s10434-015-4687-9
- Maas M, 2010, LANCET ONCOL, V11, P835, DOI 10.1016/S1470-2045(10)70172-8
- Marks JH, 2009, SURG ENDOSC, V23, P1081, DOI 10.1007/s00464-009-0326-5
- Morino M, 2013, SURG ENDOSC, V27, P3315, DOI 10.1007/s00464-013-2911-x
- Nasir I, 2019, EJSO-EUR J SURG ONC, V45, P1559, DOI 10.1016/j.ejso.2019.04.006
- Patel UB, 2012, AM J ROENTGENOL, V199, pW486, DOI 10.2214/AJR.11.8210
- Patel UB, 2012, ANN SURG ONCOL, V19, P2842, DOI 10.1245/s10434-012-2309-3
- Perez RO, 2014, TECH COLOPROCTOL, V18, P699, DOI 10.1007/s10151-013-1113-9
- Perez RO, 2012, COLORECTAL DIS, V14, P714, DOI 10.1111/j.1463-1318.2011.02761.x
- Perez RO, 2016, DIS COLON RECTUM, V59, P895, DOI 10.1097/DCR.0000000000000620
- Perez RO, 2012, INT J RADIAT ONCOL, V84, P1159, DOI 10.1016/j.ijrobp.2012.01.096
- Perez RO, 2012, CANCER-AM CANCER SOC, V118, P3501, DOI 10.1002/cncr.26644
- Perez RO, 2011, DIS COLON RECTUM, V54, P545, DOI 10.1007/DCR.0b013e3182083b84
- Renehan AG, 2016, LANCET ONCOL, V17, P174, DOI 10.1016/S1470-2045(15)00467-2
- Rymer B, 2016, CLIN NUCL MED, V41, P371, DOI 10.1097/RLU.0000000000001166
- Sao Juliao GP, 2017, COLORECTAL DIS, V19, pO196, DOI 10.1111/codi.13691
- Sauer R, 2004, NEW ENGL J MED, V351, P1731, DOI 10.1056/NEJMoa040694
- Sauer R, 2012, J CLIN ONCOL, V30, P1926, DOI 10.1200/JCO.2011.40.1836
- Sloothaak DAM, 2013, BRIT J SURG, V100, P933, DOI 10.1002/bjs.9112
- Smith JJ, 2019, JAMA ONCOL, V5, DOI 10.1001/jamaoncol.2018.5896
- Vailati BB, 2018, Dis Colon Rectum, V61, P21
- Van den Begin R, 2018, ACTA ONCOL, V57, P723, DOI 10.1080/0284186X.2017.1400689
- van der Valk MJM, 2018, LANCET, V391, P2537, DOI 10.1016/S0140-6736(18)31078-X